User profiles for Ryan O. Emerson
Ryan EmersonA-Alpha Bio Verified email at aalphabio.com Cited by 15336 |
PD-1 blockade induces responses by inhibiting adaptive immune resistance
…, C Mateus, G Tomasic, JA Glaspy, RO Emerson… - Nature, 2014 - nature.com
Therapies that target the programmed death-1 (PD-1) receptor have shown unprecedented
rates of durable clinical responses in patients with various cancer types 1 , 2 , 3 , 4 , 5 . One …
rates of durable clinical responses in patients with various cancer types 1 , 2 , 3 , 4 , 5 . One …
[HTML][HTML] Innate immune landscape in early lung adenocarcinoma by paired single-cell analyses
To guide the design of immunotherapy strategies for patients with early stage lung tumors,
we developed a multiscale immune profiling strategy to map the immune landscape of early …
we developed a multiscale immune profiling strategy to map the immune landscape of early …
Radiotherapy induces responses of lung cancer to CTLA-4 blockade
…, A Heguy, N Imai, S Gnjatic, RO Emerson… - Nature medicine, 2018 - nature.com
Focal radiation therapy enhances systemic responses to anti-CTLA-4 antibodies in preclinical
studies and in some patients with melanoma 1 , 2 – 3 , but its efficacy in inducing systemic …
studies and in some patients with melanoma 1 , 2 – 3 , but its efficacy in inducing systemic …
[HTML][HTML] Using synthetic templates to design an unbiased multiplex PCR assay
CS Carlson, RO Emerson, AM Sherwood… - Nature …, 2013 - nature.com
T and B cell receptor loci undergo combinatorial rearrangement, generating a diverse
immune receptor repertoire, which is vital for recognition of potential antigens. Here we use a …
immune receptor repertoire, which is vital for recognition of potential antigens. Here we use a …
Immunosequencing identifies signatures of cytomegalovirus exposure history and HLA-mediated effects on the T cell repertoire
An individual's T cell repertoire dynamically encodes their pathogen exposure history. To
determine whether pathogen exposure signatures can be identified by documenting public T …
determine whether pathogen exposure signatures can be identified by documenting public T …
[HTML][HTML] Adaptive evolution in zinc finger transcription factors
RO Emerson, JH Thomas - PLoS genetics, 2009 - journals.plos.org
The majority of human genes are conserved among mammals, but some gene families have
undergone extensive expansion in particular lineages. Here, we present an evolutionary …
undergone extensive expansion in particular lineages. Here, we present an evolutionary …
Fractionated radiation therapy stimulates antitumor immunity mediated by both resident and infiltrating polyclonal T-cell populations when combined with PD-1 …
Purpose: Radiotherapy is a highly effective anticancer treatment forming part of the standard
of care for the majority of patients, but local and distal disease recurrence remains a major …
of care for the majority of patients, but local and distal disease recurrence remains a major …
[HTML][HTML] Common clonal origin of central and resident memory T cells following skin immunization
O Gaide, RO Emerson, X Jiang, N Gulati, S Nizza… - Nature medicine, 2015 - nature.com
Central memory T (T CM ) cells in lymph nodes (LNs) and resident memory T (T RM ) cells
in peripheral tissues have distinct roles in protective immunity 1 , 2 , 3 , 4 , 5 . Both are …
in peripheral tissues have distinct roles in protective immunity 1 , 2 , 3 , 4 , 5 . Both are …
High-throughput pairing of T cell receptor α and β sequences
…, AD Berkebile, J Berka, RO Emerson… - Science translational …, 2015 - science.org
The T cell receptor (TCR) protein is a heterodimer composed of an α chain and a β chain.
TCR genes undergo somatic DNA rearrangements to generate the diversity of T cell binding …
TCR genes undergo somatic DNA rearrangements to generate the diversity of T cell binding …
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
…, RS Slack, L Vence, RO Emerson… - Proceedings of the …, 2016 - National Acad Sciences
Immune checkpoint therapies, such as ipilimumab, induce dramatic antitumor responses in
a subset of patients with advanced malignancies, but they may also induce inflammatory …
a subset of patients with advanced malignancies, but they may also induce inflammatory …